GNH USA

Europe — EMA

Nebivolol Medreg

GNH USA supplies Nebivolol Medreg (Nebivolol), a selective β1‑adrenergic antagonist beta‑blocker indicated for hypertension.

Nebivolol

Request sourcing

1
Pack/s

What is Nebivolol?

Nebivolol, the active ingredient in Nebivolol Medreg, is a Beta‑blocker (selective β1‑adrenergic antagonist) presented as an oral tablet for oral use. It treats hypertension by lowering blood pressure in adult patients.

GNH USA supplies Nebivolol Medreg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nebivolol used for?

Nebivolol is a selective β1‑adrenergic blocker used in the management of hypertension, helping to control elevated blood pressure.

- Hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension.

What are the side effects of Nebivolol?

Nebivolol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often transient. - Dizziness: sensation of light‑headedness, especially on standing. - Fatigue: reduced energy or feeling unusually tired. - Nasal congestion: blockage or runny nose.

Serious or Rare Side Effects: - Severe bradycardia: markedly slow heart rate requiring medical attention. - Hypotension: dangerously low blood pressure. - Heart block: impaired electrical conduction of the heart. - Bronchospasm: narrowing of airways, particularly in patients with reactive airway disease. - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Elevated liver enzymes: abnormal liver function tests.

What precautions apply to Nebivolol?

Before initiating Nebivolol, clinicians should evaluate patient‑specific factors and monitor for potential risks. - Blood pressure monitoring: check regularly to ensure therapeutic effect. - Heart rate assessment: observe for excessive bradycardia. - Asthma or chronic obstructive pulmonary disease: use with caution due to possible bronchospasm. - Concomitant beta‑blocker therapy: avoid duplicate therapy. - Abrupt discontinuation: taper gradually to prevent rebound hypertension. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

What does Nebivolol interact with?

Nebivolol can interact with several medicines; some combinations should be avoided while others require close observation.

Major Interactions (Avoid): - Other beta‑blockers: additive cardiac depression. - Non‑dihydropyridine calcium channel blockers (verapamil, diltiazem): risk of severe bradycardia. - Amiodarone: enhanced negative chronotropic effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential for excessive blood pressure reduction. - Diuretics: may increase risk of electrolyte imbalance and hypotension.

Frequently asked questions

What is Nebivolol Medreg used for?+
Nebivolol Medreg is prescribed to lower elevated blood pressure in adults with primary hypertension. By reducing both systolic and diastolic pressures, it helps prevent complications such as stroke, heart attack, and kidney damage associated with uncontrolled hypertension.
How does nebivolol work to lower blood pressure?+
Nebivolol selectively blocks β1‑adrenergic receptors in the heart, decreasing heart rate and contractile force. At the same time, it enhances nitric‑oxide release from the endothelium, causing vasodilation. The combined effect reduces cardiac output and peripheral resistance, leading to lower blood pressure.
What is the usual dose of nebivolol?+
The appropriate dose of nebivolol is determined by the prescribing clinician based on the patient’s medical condition, response to therapy, and any concomitant medications. Dosage adjustments may be required for special populations, and patients should follow the prescriber’s instructions exactly.
Is nebivolol safe during pregnancy or breastfeeding?+
Safety data for nebivolol in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified health professional.
How do I order Nebivolol Medreg from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does nebivolol compare with other antihypertensive drugs?+
Nebivolol differs from many beta‑blockers by adding nitric‑oxide‑mediated vasodilation, which can improve endothelial function and reduce peripheral resistance. Compared with non‑selective beta‑blockers, it has a lower risk of bronchospasm, making it a preferred option for patients with respiratory concerns.
What are the storage and handling requirements for nebivolol Medreg?+
Nebivolol Medreg should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.
How is nebivolol administered?+
Nebivolol is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless otherwise directed by a healthcare professional.
What are the most serious risks associated with nebivolol?+
Serious risks include severe bradycardia, marked hypotension, heart block, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, swelling of the face or throat, or any signs of a severe allergic response.
Who should not use nebivolol?+
Nebivolol is contraindicated in patients with known hypersensitivity to the drug, those with severe bradycardia, second‑ or third‑degree atrioventricular block without a pacemaker, and individuals taking certain interacting medications such as other beta‑blockers or non‑dihydropyridine calcium channel blockers without careful monitoring.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nebivolol
Route
Oral Use
Manufacturer
Medreg S.R.O.
Origin
EU

Related products

Nebivolol 20 mg/1

Nebivolol 20 mg/1

Nebivolol · 20 mg

nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 2.5 mg/1

NEBIVOLOL 2.5 mg/1

Nebivolol · 2.5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 5 mg/1

NEBIVOLOL 5 mg/1

Nebivolol · 5 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA
NEBIVOLOL 10 mg/1

NEBIVOLOL 10 mg/1

Nebivolol · 10 mg

Nebivolol
TABLET
Major Pharmaceuticals
USA